Skip to main content
SpringerLink
Log in

So wirksam wie die Standardtherapie

H3-Rezeptoragonist in der Behandlung der Narkolepsie

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Lażewska D et al. Expert Opin Ther Pat 2013 Oct 17 [Epub ahead of print]

  2. Inocente C et al. Clin Neuropharmacol 2012; 35: 55–60

    Article  PubMed  CAS  Google Scholar 

  3. Kasteleijn-Nolst Trenitè DG et al. Epilepsy Behav 2013; 28: 66–70

    Article  PubMed  Google Scholar 

Literatur

  • Dauvilliers Y, Bassetti C, Lammers GJ et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol 2013; 12: 1068–75

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Neurologie, Innsbruck Austria, Innsbruck, Österreich

    Birgit Högl

Authors
  1. Birgit Högl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Birgit Högl.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Högl, B. So wirksam wie die Standardtherapie. InFo Neurologie 16, 35–36 (2014). https://doi.org/10.1007/s15005-014-0813-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-014-0813-7

Search

Navigation